Kalaris Therapeutics KLRS
NASDAQ KLRS
$2.90 +0.06 (+1.93%)
At close: Sep 29, 2026 · 4:00 PM EDT

Kalaris Therapeutics (KLRS) Current Taxes (2021 - 2023)

Updated

Kalaris Therapeutics (KLRS) reported Current Taxes of $127,000 for Q2 2023, down 17.5% from $154,000 a year earlier and down 2.3% from the prior quarter.

Analysis

Kalaris Therapeutics (KLRS) Current Taxes (2021 - 2023) Analysis & Trends

At the end of FY2022, Kalaris Therapeutics posted Current Taxes of $128,000, down 87.3% from FY2021.

  • By year, Current Taxes came in at $1.01 million in FY2021.
  • Year over year, Current Taxes has now declined in each of the last three quarters.
  • Per Business Quant data, the three quarters before Q2 2023 came in at $130,000 (Q1 2023), $128,000 (Q4 2022) and $154,000 (Q3 2022).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Taxes (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 1.05 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn -
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 4.22 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 2.31 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -1.47 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn -
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 653.00 Mn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 Kalaris Therapeutics 67.84 Mn 67.84 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 127,000.00
Mar 31, 2023 130,000.00
Dec 31, 2022 128,000.00
Sep 30, 2022 154,000.00
Jun 30, 2022 154,000.00
Mar 31, 2022 507,000.00
Dec 31, 2021 1.01 Mn
API Access

Kalaris Therapeutics Current Taxes API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-taxes&ticker=KLRS&period=max&api_key=YOUR_API_KEY